The VPS33B-binding protein VPS16B is required in megakaryocyte and platelet α-granule biogenesis

  • Denisa Urban
    Department of Biochemistry, University of Toronto, Toronto, ON;
  • Ling Li
    Program in Cell Biology, The Hospital for Sick Children, Toronto, ON;
  • Hilary Christensen
    Program in Cell Biology, The Hospital for Sick Children, Toronto, ON;
  • Fred G. Pluthero
    Program in Cell Biology, The Hospital for Sick Children, Toronto, ON;
  • Shao Zun Chen
    Department of Biochemistry, University of Toronto, Toronto, ON;
  • Michael Puhacz
    Department of Biochemistry, University of Toronto, Toronto, ON;
  • Parvesh M. Garg
    Department of Pediatrics, Neonatology Section, The Brody School of Medicine at East Carolina University, Greenville, NC;
  • Kiran K. Lanka
    Department of Pediatrics, Neonatology Section, The Brody School of Medicine at East Carolina University, Greenville, NC;
  • James J. Cummings
    Department of Pediatrics, Neonatology Section, The Brody School of Medicine at East Carolina University, Greenville, NC;
  • Helmut Kramer
    Departments of Neuroscience and Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX;
  • James D. Wasmuth
    Departments of Biochemistry & Molecular Genetics, University of Toronto, Program in Molecular Structure & Function, The Hospital for Sick Children, Toronto, ON; and
  • John Parkinson
    Departments of Biochemistry & Molecular Genetics, University of Toronto, Program in Molecular Structure & Function, The Hospital for Sick Children, Toronto, ON; and
  • Walter H. A. Kahr
    Department of Biochemistry, University of Toronto, Toronto, ON;

説明

<jats:title>Abstract</jats:title> <jats:p>Patients with platelet α or dense δ-granule defects have bleeding problems. Although several proteins are known to be required for δ-granule development, less is known about α-granule biogenesis. Our previous work showed that the BEACH protein NBEAL2 and the Sec1/Munc18 protein VPS33B are required for α-granule biogenesis. Using a yeast two-hybrid screen, mass spectrometry, coimmunoprecipitation, and bioinformatics studies, we identified VPS16B as a VPS33B-binding protein. Immunoblotting confirmed VPS16B expression in various human tissues and cells including megakaryocytes and platelets, and also in megakaryocytic Dami cells. Characterization of platelets from a patient with arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome containing mutations in C14orf133 encoding VPS16B revealed pale-appearing platelets in blood films and electron microscopy revealed a complete absence of α-granules, whereas δ-granules were observed. Soluble and membrane-bound α-granule proteins were reduced or undetectable, suggesting that both releasable and membrane-bound α-granule constituents were absent. Immunofluorescence microscopy of Dami cells stably expressing GFP-VPS16B revealed that similar to VPS33B, GFP-VPS16B colocalized with markers of the trans-Golgi network, late endosomes and α-granules. We conclude that VPS16B, similar to its binding partner VPS33B, is essential for megakaryocyte and platelet α-granule biogenesis.</jats:p>

収録刊行物

  • Blood

    Blood 120 (25), 5032-5040, 2012-12-13

    American Society of Hematology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ